Korro Bio (KRRO) Tax Provisions (2020 - 2026)
Korro Bio (KRRO) posted Tax Provisions of $95000.0 for Q1 2026, up 100.39% on a QoQ basis from -$24.5 million in Q4 2025.
Korro Bio (KRRO) Tax Provisions (2020 - 2026) Analysis & Trends
Korro Bio's Tax Provisions history runs 7 years deep, the most recent figure standing at $95000.0 for Q1 2026.
- Quarterly Tax Provisions changed N/A year-over-year to $95000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.4 million (down 19773.39% YoY) and the FY2025 annual result came in at -$24.5 million, down 17468.79% from the prior year.
- Tax Provisions was $95000.0 for Q1 2026 at Korro Bio, up from -$24.5 million in the prior quarter.
- Across five years, Tax Provisions topped out at $103000.0 in Q4 2024 and bottomed at -$24.5 million in Q4 2025.
- A 5-year average of -$2.0 million and a median of $14500.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions jumped 1250.0% — and 2025, when it sank 23877.67%.
- Korro Bio's Tax Provisions stood at $19000.0 in 2022, then soared by 42.11% to $27000.0 in 2023, then soared by 281.48% to $103000.0 in 2024, then sank by 23877.67% to -$24.5 million in 2025, then soared by 100.39% to $95000.0 in 2026.
- Business Quant data shows KRRO's Tax Provisions at $95000.0 in Q1 2026, -$24.5 million in Q4 2025, and $1000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Korro Bio | 120.63 Mn | 6.66 Mn | - | 95,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | -24.49 Mn |
| Jun 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Jun 30, 2023 | 27,000.00 |
| Dec 31, 2022 | 19,000.00 |
| Sep 30, 2022 | -23,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Dec 31, 2020 | -25,000.00 |
| Sep 30, 2020 | 15,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 38,000.00 |